000272581 001__ 272581
000272581 005__ 20250314091251.0
000272581 0247_ $$2doi$$a10.1007/s00415-024-12649-x
000272581 0247_ $$2pmid$$apmid:39192030
000272581 0247_ $$2pmc$$apmc:PMC11447035
000272581 0247_ $$2ISSN$$a0367-004X
000272581 0247_ $$2ISSN$$a0012-1037
000272581 0247_ $$2ISSN$$a0340-5354
000272581 0247_ $$2ISSN$$a1432-1459
000272581 037__ $$aDZNE-2024-01202
000272581 041__ $$aEnglish
000272581 082__ $$a610
000272581 1001_ $$00000-0001-7680-2147$$aPötter-Nerger, Monika$$b0
000272581 245__ $$aAkinetic crisis and withdrawal syndromes: guideline 'Parkinson's disease' of the German Society of Neurology.
000272581 260__ $$aHeidelberg$$bSpringer$$c2024
000272581 3367_ $$2DRIVER$$aarticle
000272581 3367_ $$2DataCite$$aOutput Types/Journal article
000272581 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1729170220_2185$$xReview Article
000272581 3367_ $$2BibTeX$$aARTICLE
000272581 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000272581 3367_ $$00$$2EndNote$$aJournal Article
000272581 520__ $$aThe akinetic crisis is a well-known, rare, potentially life-threatening condition in Parkinson's disease with subacute worsening of akinesia, rigidity, fever, impaired consciousness, accompanying vegetative symptoms and transient dopa-resistance. The akinetic crisis was historically supposed to be a 'withdrawal syndrome' in the sense of discontinuation of dopaminergic medication. Recently, other 'withdrawal syndromes' as the specific 'dopamine agonist withdrawal syndrome' or 'deep brain stimulation withdrawal syndrome' have been described as emergency situations with specific subacute symptom constellations. All three conditions require immediate start of the adequate therapy to improve the prognosis. Here, the diagnostic criteria and treatment options of these three acute, severely disabling syndromes will be reported along the current guidelines of the German Parkinson Guideline Group.
000272581 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000272581 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000272581 650_7 $$2Other$$aAkinetic crisis
000272581 650_7 $$2Other$$aDeep brain stimulation withdrawal syndrome
000272581 650_7 $$2Other$$aDiagnostic criteria
000272581 650_7 $$2Other$$aDopamine agonist withdrawal syndrome
000272581 650_7 $$2Other$$aGerman Parkinson Guideline
000272581 650_7 $$2Other$$aTherapy
000272581 650_7 $$2NLM Chemicals$$aAntiparkinson Agents
000272581 650_2 $$2MeSH$$aHumans
000272581 650_2 $$2MeSH$$aParkinson Disease: drug therapy
000272581 650_2 $$2MeSH$$aParkinson Disease: diagnosis
000272581 650_2 $$2MeSH$$aParkinson Disease: therapy
000272581 650_2 $$2MeSH$$aSubstance Withdrawal Syndrome: diagnosis
000272581 650_2 $$2MeSH$$aGermany
000272581 650_2 $$2MeSH$$aNeurology: standards
000272581 650_2 $$2MeSH$$aSocieties, Medical: standards
000272581 650_2 $$2MeSH$$aAntiparkinson Agents: therapeutic use
000272581 650_2 $$2MeSH$$aAntiparkinson Agents: adverse effects
000272581 650_2 $$2MeSH$$aDeep Brain Stimulation: standards
000272581 650_2 $$2MeSH$$aPractice Guidelines as Topic: standards
000272581 7001_ $$0P:(DE-2719)2813524$$aLöhle, Matthias$$b1$$udzne
000272581 7001_ $$0P:(DE-2719)2811373$$aHöglinger, Günter$$b2$$eLast author$$udzne
000272581 7001_ $$aGroup, German Parkinson‘s Guideline$$b3$$eCollaboration Author
000272581 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-024-12649-x$$gVol. 271, no. 10, p. 6485 - 6493$$n10$$p6485 - 6493$$tJournal of neurology$$v271$$x0367-004X$$y2024
000272581 8564_ $$uhttps://pub.dzne.de/record/272581/files/DZNE-2024-01202.pdf$$yOpenAccess
000272581 8564_ $$uhttps://pub.dzne.de/record/272581/files/DZNE-2024-01202.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000272581 909CO $$ooai:pub.dzne.de:272581$$pdriver$$pVDB$$popen_access$$popenaire$$pdnbdelivery
000272581 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2813524$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000272581 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811373$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000272581 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000272581 9141_ $$y2024
000272581 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2022$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000272581 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000272581 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NEUROL : 2022$$d2023-10-21
000272581 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000272581 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000272581 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000272581 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000272581 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000272581 9201_ $$0I:(DE-2719)1110002$$kAG Höglinger$$lTranslational Neurodegeneration$$x1
000272581 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x2
000272581 980__ $$ajournal
000272581 980__ $$aVDB
000272581 980__ $$aUNRESTRICTED
000272581 980__ $$aI:(DE-2719)1111015
000272581 980__ $$aI:(DE-2719)1110002
000272581 980__ $$aI:(DE-2719)1510100
000272581 9801_ $$aFullTexts